Key Developments: Masimo Corp (MASI.OQ)

MASI.OQ on NASDAQ Stock Exchange Global Select Market

26 Nov 2014
Price Change (% chg)

$0.28 (+1.07%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

Masimo Corp lowers FY 2014 revenue outlook; updates FY 2014 EPS outlook - Conference Call
Wednesday, 29 Oct 2014 04:30pm EDT 

Masimo Corp:Lowers FY 2014 total revenue guidance from previous FY 2014 range of $588 million to $593 million to about $585 million, including about $556 million in product revenues and $29 million in royalty revenues.Expects to report FY 2014 earnings-per-share of about $1.28, within the prior range of $1.24 to $1.30 per diluted share.FY 2014 revenue of $587 mln and EPS of $1.24 - Thomson Reuters I/B/E/S.  Full Article

two new clinical studies show Masimo Noninvasive Hemoglobin (SpHb) demonstrated similar precision as hemoglobin from point of care devices
Thursday, 16 Oct 2014 08:01am EDT 

Masimo Corp:Announced the two new studies on Oct. 16 showed that noninvasive hemoglobin (SpHb) demonstrated similar accuracy as hemoglobin measured by invasive hemoglobin analyzers when both SpHb and the invasive hemoglobin analyzer were compared to laboratory hematology analyzer.Says Masimo SpHb showed similar absolute and trending accuracy as hemoglobin values determined by a laboratory blood gas analyzer, when both the SpHb and the hemoglobin from the blood gas analyzer were compared to hemoglobin from a laboratory hematology analyzer.  Full Article

Masimo Corp announces CE Mark and Limited Market Release of rainbow DCI-mini
Thursday, 28 Aug 2014 08:03am EDT 

Masimo Corp:Says CE Mark, clearance in Japan, and limited market release of the rainbow DCI-mini, a noninvasive haemoglobin (SpHb) spot-check sensor for infants and small children (weight 3 to 30 kg).Paired with Masimo's handheld Pronto device, the rainbow DCI-mini sensors are designed to help clinicians quickly and easily spot-check haemoglobin levels.  Full Article

Masimo Corp lowers high end of prior FY 2014 revenue outlook to a range in line with analysts' estimates
Thursday, 7 Aug 2014 04:11pm EDT 

Masimo Corp:Now expects FY 2014 total revenue to be about $588 to $593 million.FY 2014 GAAP earnings per diluted share to range between $1.24 and $1.30.FY 2014 revenue of $590 mln, EPS of $1.28 - Thomson Reuters I/B/E/S.  Full Article

Masimo Corp announces CE mark and limited market release of Radius-7
Tuesday, 29 Jul 2014 02:00am EDT 

Masimo Corp:Says CE Mark and limited market release of Radius-7 for the Root patient monitoring and connectivity platform.  Full Article

Masimo announces CE Mark of iSpO2 Rx Pulse Oximeter for Mobile Devices
Thursday, 29 May 2014 07:58am EDT 

Masimo Corp:Says iSpO2 Rx Pulse Oximeter for Android and iOS devices receives CE Mark clearance for medical use in select countries, offering clinicians the power of Masimo SET Measure-through Motion and Low Perfusion Pulse Oximetry on their smart phones and tablets.  Full Article

Masimo Corp's subsidiary completes acquisition of land - Form 8-K
Friday, 16 May 2014 04:44pm EDT 

Masimo Corp's subsidiary:Says on May 12, it completed purchase of land and 213,800 square foot building located in Irvine, California from Nikken, Inc.Pursuant to purchase agreement, purchase price of the property was $56.0 million excluding adjustments, reimbursements, prorations and credits.  Full Article

Masimo Corp updates FY 2014 revenue outlook to a range above analysts' estimates; raises FY 2014 EPS outlook
Wednesday, 30 Apr 2014 04:05pm EDT 

Masimo Corp:Expects FY 2014 total revenue to be about $588 -$598 mln.Expects FY 2014 GAAP earnings per share to range between $1.24 and $1.33.FY 2014 revenue of $578 mln, EPS of $1.15 - Thomson Reuters I/B/E/S.  Full Article

Masimo Corp enters into purchase and sale agreement with Nikken Inc - Form 8-K
Tuesday, 18 Mar 2014 04:55pm EDT 

Masimo Corp:Enters into the Fourth Amendment to Purchase and Sale Agreement with Nikken, Inc.Agreed to purchase from Nikken the land and a 213,400 square foot building located in, Irvine, California.Intends to use the Property primarily as new corporate and research and development headquarters.Purchase price of the Property will be $56.0 mln.  Full Article

Masimo Corp reaffirms FY 2014 guidance - Conference Call
Tuesday, 4 Mar 2014 07:30am EST 

Masimo Corp:Expects FY 2014 top-line revenue growth of 10 pct-ish, which will take up to about $570 million in total product revenues.Says as part of guidance this year it also suggested royalties could range somewhere between $8 million to $28 million.Expects FY 2014 earnings-per-share guidance of $1.13 to $1.28.FY 2014 revenue of $579 million and EPS of $1.15 - Thomson Reuters I/B/E/S.  Full Article


Philips Electronics to appeal ruling in $467 million patent lawsuit

- Dutch healthcare equipment company Philips said on Thursday it would appeal against a U.S court ruling ordering it to pay $466.8 million in compensation to Masimo Corp for infringing two patents.

Search Stocks